-
Archives
- June 2021
- February 2020
- August 2018
- July 2018
- June 2018
- July 2017
- May 2017
- January 2017
- October 2016
- June 2016
- March 2016
- January 2016
- November 2015
- August 2015
- July 2015
- June 2015
- May 2015
- June 2014
- May 2014
- April 2014
- December 2012
- September 2012
- July 2012
- May 2012
- April 2012
- February 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
-
Meta
Author Archives: C. Kubler
USP Opens Call for Volunteers to Serve on Expert Committees
The Coalition would like to make the nuclear medicine community aware of USP Volunteer Opportunities for pharmacists, chemists, practitioners, regulatory professionals, and other scientists with expertise in radiopharmaceuticals. Every five years, the USP invites qualified candidates to apply for service … Continue reading
Posted in PET Drugs
Leave a comment
Coalition for PET Drugs Meeting Presentation Available
On June 26, 2018, the Coalition for PET Drugs held a meeting at the 2018 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Philadelphia. The meeting was attended by numerous members of the Coalition, as … Continue reading
Posted in PET Drugs
Leave a comment
USP Presentations from SNMMI Annual Meeting Available
On June 24, 2018, the United States Pharmacopeia (USP) and the Coalition for PET Drugs co-sponsored a session at the 2018 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Philadelphia. The session was entitled “USP … Continue reading
Posted in PET Drugs
Leave a comment
Coalition for PET Drugs Sponsors Three Sessions at SNMMI Annual Meeting
The Coalition for PET Drugs recently sponsored three sessions at the 2017 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Denver. The sessions focused on various topics relevant to PET drug manufacturers. Each session drew … Continue reading
Posted in PET Drugs
Leave a comment
SNMMI Comments to FDA on Compounding
SNMMI submitted comments to the FDA on draft guidance “Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies.” The guidance explains that, under current law, radiopharmaceuticals compounded or repackaged by state-licensed nuclear pharmacies and federal facilities are subject to all … Continue reading
Posted in PET Drugs
Leave a comment
SNMMI Develops USP Recommendations for Compounded Sterile Radiopharmaceuticals
SNMMI has developed USP recommendations for compounded sterile radiopharmaceuticals. The recommendations aim to address certain common practices in the field of nuclear pharmacy that are not adequately defined by generally accepted practice standards. The society believes there is confusion in … Continue reading
Posted in PET Drugs
Leave a comment
FDA Issues Draft Guidances on Compounding and Repackaging Radiopharmaceuticals
On December 28th, the FDA issued two draft guidances that describe FDA’s proposed policies regarding the compounding and repackaging of radiopharmaceuticals for human use by state-licensed nuclear pharmacies or federal facilities, and outsourcing facilities. According to FDA, “the policies proposed … Continue reading
Posted in PET Drugs
Leave a comment
FDA Releases SBIA Summary of eCTD Requirements
The U.S. Food and Drug Administration recently released a summary of the movement to require certain regulatory submissions to conform to the electronic Common Technical Document (eCTD) format. The eCTD has been the standard format for submitting applications, amendments, supplements, … Continue reading
Posted in PET Drugs
Leave a comment
NRC Licensing Guidance for Eckert and Ziegler Ge-68/Ga-68 Generator
On September 28, 2016, the U.S. Nuclear Regulatory Commission published Licensing Guidance for Eckert and Ziegler GalliaPharm Germanium-68/Gallium-68 Pharmacy Grade Generator. All sections of this guidance apply to both medical licensee and commercial nuclear pharmacy licensee use of this generator … Continue reading
Posted in PET Drugs
Leave a comment
Sponsored Session from SNMMI Annual Meeting:PET Drug Manufacturing: Living in an FDA-Regulated World
The Coalition for PET Drugs recently sponsored a session focused on FDA topics relevant to PET drug manufacturers. The session was held at the 2016 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in San Diego. … Continue reading
Posted in PET Drugs
Leave a comment